Literature and evidence database
Find the source, the model and the boundary.
Search source records connected to the product-family knowledge base. Filter by category, product, publication year, research type, study model and editorial evidence tier.
Product evidence maps
A focused source set for each product.
Search and filter
Evidence records
Narrow the records by product, year or study model. Open each source to check its results and limitations.
Performance-enhancing peptides modulating the GH-IGF1 axis
Critical review. 2026. PMID 42395176.
Enzymatic and serum stability of GHRP and GHRH-related peptides
Analytical study. 2023. PMID 37688464.
Certain Bulk Drug Substances That May Present Significant Safety Risks
U.S. FDA. Current compounding safety-information page.
WADA 2026 Prohibited List
Official list prohibits mechano growth factors.
MGF E peptide showed no apparent myoblast effect
Null cell and primary muscle-stem-cell study; PMID 24253050.
MGF peptide delivery from PEGDMA microrods
Biomaterials delivery study using native MGF in a PEGDMA matrix; PMID 24908137.
Localized MGF E-domain delivery after mouse myocardial infarction
Mouse cardiac delivery study using peptide-eluting polymeric microstructures; PMID 25678113.
Editorial methodology
How records are classified
Records are deduplicated by source URL and linked to every relevant product family. Study type and model are inferred from the citation and editorial evidence label, then reviewed during content QA.
Read the full editorial, AI-assistance and correction policy →
Labels and databases supporting regulatory status, formulation or chemical identity.
Controlled trials, systematic reviews and other clinical records with population-specific interpretation.
Animal, cell, analytical and mechanistic records that cannot establish human outcomes.
Narrative reviews, registries and sponsor reports kept visibly distinct from peer-reviewed outcomes.
Use the records